Neurocrine s Monday’s IBD Stock Of The Day. Milestones are stacking up in 2024 and Neurocrine stock just topped its 50-day line.

The post The $1 Billion Opportunity Driving IBD Stock Of The Day Neurocrine Higher appeared first on Investor’s Business Daily.